Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer.
| Image |  |
|---|---|
| Description | scientific article published on 23 February 2018 |
| Author/s |
author: Bradly Wouters Trevor McKee Catherine A O'Brien David A. Jaffray |
| Publication date | February 23, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |